Related Experiment Video
Updated: May 22, 2026
08:39
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Viral hepatitis in liver transplantation
Gonzalo Crespo1, Zoe Mariño, Miquel Navasa
1Liver Unit, Hospital Clinic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Gastroenterology
|April 28, 2012
Summary
Liver transplantation offers hope for end-stage liver disease. While hepatitis B is manageable post-transplant, hepatitis C recurrence remains a significant challenge, though new antivirals promise better outcomes.
Area of Science:
- Hepatology and Transplant Surgery
- Virology and Infectious Diseases
Background:
- Liver transplantation is a critical treatment for end-stage liver disease.
- Hepatitis B and C are leading causes of cirrhosis, hepatocellular carcinoma, and liver transplant indications.
- Hepatitis B management post-transplant has improved outcomes.
Purpose of the Study:
- To review the impact of viral hepatitis on liver transplant outcomes.
- To compare the management and outcomes of hepatitis B and C in liver transplant recipients.
- To discuss the evolving therapeutic landscape for hepatitis C in transplant patients.
Main Methods:
- Literature review of studies on viral hepatitis in liver transplantation.
- Analysis of treatment strategies for hepatitis B and C post-transplant.
- Evaluation of current and emerging therapies for hepatitis C virus (HCV).
Main Results:
- Hepatitis B is effectively managed with immunoglobulin and nucleos(t)ide analogues, leading to excellent long-term outcomes.
- Hepatitis C recurrence is a primary cause of graft loss, with suboptimal response rates to current therapies.
- Adverse effects of current hepatitis C treatments are frequent and severe.
Conclusions:
- Hepatitis B post-liver transplant is generally well-controlled.
- Hepatitis C recurrence post-transplant remains a major clinical challenge.
- Direct-acting antivirals are expected to revolutionize hepatitis C management and prevent graft reinfection.
Related Concept Videos
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...